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Cornified envelopes and apoptotic bodies are trans- 
glutaminase-cross-linked end-products of physiologi- 
cal cell death pathways. The two structures have sim- 
ilar amino acid composition. Involucrin has been con- 
sidered as a cornified envelope precursor protein 
expressed specifically in terminally differentiating 
keratinocytes and  squamous epithelia. We report the 
presence in hepatocytes of an involucrin-like protein 
which could be purified from dog liver  with procedures 
characteristic to involucrins. When  compared  to puri- 
fied dog esophagus involucrin, the liver protein also 
reacts with anti-involucrin antibodies, has the same 
relative molecular mass, possesses similar amino acid 
composition, and shows almost identical peptide map- 
ping pattern. The involucrin-like protein is detectable 
by immunohistochemistry in normal  and apoptotic he- 
patocytes, is a substrate of tissue transglutaminase, 
and is incorporated into cross-linked apoptotic bodies. 
These results suggest that there are overlapping mo- 
lecular components in the two characteristic forms 
(cornification and apoptosis) of naturally occurring 
cell death. 
~ ~ ~ ~~ ~~ 
Transglutaminases (EC 2.3.2.13) are a family of calcium- 
dependent enzymes, which form t(y-glutamy1)lysine cross- 
links between  polypeptide chains (1) giving them  character- 
istic  resistance  against physicochemical,  mechanical, and  en- 
zymatic actions (1, 2). Two of the transglutaminases are 
involved in biochemical .events linked to cell death. The 
membrane-bound keratinocyte transglutaminase is induced 
during cornification and produces protein envelopes beneath 
the plasma  membrane of terminally  differentiating  keratino- 
cytes  and  squamous  epithelial cells (3). The cytosolic tissue 
transglutaminase (4) participates  in  the biochemical pathway 
of  apoptosis, which is  the physiological cell death  program  in 
parenchymal  tissues  and  non-squamous  epithelia  to  eliminate 
individual cells as  part of embryonic development  and  normal 
cell  turnover (5). The dying  cells  preserve their  integrity  and 
form membrane-enclosed apoptotic bodies (6, 7). The prod- 
* This work was supported by Hungarian Science and Research 
Fund Grant OTKA III/1465 and by Hungarian  Ministry of Welfare 
Grant TO1 T-482/1990. The costs of publication of this article were 
defrayed in part by the payment of page charges. This article must 
therefore be hereby marked “advertisement” in accordance with 18 
U.S.C. Section 1734  solely to indicate this fact. 
8 To whom correspondence should be addressed Dept. of Biochem- 
istry, University Medical School Debrecen H-4012, P. 0. Box 6, 
Hungary. Tel.: 36-52-16-432; Fax: 36-52-13-847. 
ucts of these two processes are highly cross-linked protein 
scaffolds that  are  resistant  to  detergents  and  chaotropic 
agents (6, 8). Cornification has  been extensively  investigated 
(81, and a number of proteins  have  been identified as envelope 
precursors.  However, nothing is known about  the  substrates 
of tissue  transglutaminase  in apoptosis. The  first discovered 
and most extensively studied substrate of the keratinocyte 
transglutaminase is involucrin (9, lo), which is synthesized 
in  the  outer half of the  spinous layer in epidermis, localized 
in  the  cytoplasm,  then  concentrated  at  the  periphery of dif- 
ferentiating cells to  be  incorporated  into  the cornified enve- 
lope. 
We report that the amino acid composition of cornified 
envelopes and  apoptotic bodies are very similar  and  an invol- 
ucrin-like  protein  can  be  isolated from hepatocytes which is 
incorporated  into  apoptotic bodies by tissue  transglutaminase. 
EXPERIMENTAL  PROCEDURES 
Materials 
Rabbit anti-human-133 involucrin antibody (raised against resi- 
dues 2-21 of the N-terminal  ancestral segment of human involucrin) 
and a  rabbit  anti-dog involucrin antibody (11) were kind gifts of Dr. 
Marcia Simon (State University of New York, Stony Brook, New 
York). The rabbit anti-cornified envelope antibody (raised against 
cornified envelopes of SV-40 transformed human foreskin keratino- 
cyte line SV-K14, Ref. 12) was a kind gift of Dr. Rainer Schmidt 
(Centre  Internationale de Recherche5 Dermatologiques GALD- 
ERMA, France). 
Preparation and Characterization of Cornified  Envelopes and 
Apoptotic  Bodies 
Cornified  envelopes of human foreskin and rat tail skin were 
purified with sodium dodecyl sulfate extraction as described by Rice 
and Green (2). Detergent-resistant apoptotic  bodies  from rat  and dog 
liver were isolated as described earlier (6). 
Amino Acid Analysis-The acid hydrolyzed samples were deriva- 
tized with phenylisothiocyanate (13) and separated by HPLC’ on a 
C18 column (0.4 X 25 cm, 5 Fm, BST, Budapest, Hungary). Detection 
was carried out a t  254 nm, and  the amount of the amino acids was 
determined with the help of standards. 
Cyanogen Bromide Fragmentation-Samples were incubated with 
a 100-fold molar excess of CNBr for 24 h at room temperature in 
70% formic acid. The fragments were dissolved in 10% trifluoroacetic 
acid for dot blot analysis or in denaturing solution for SDS-PAGE. 
Digestion  with Proteinase K-Samples  were suspended in 25 mM 
Tris-HC1 buffer, pH 7.6, containing 0.1% SDS and digested for 5 
days. The fragments were separated by SDS-PAGE and transferred 
to nitrocellulose membrane. Western blot was performed using anti- 
dog involucrin antibody and detected with ECL (enhanced chemilu- 
minescence detection system, Amersham). 
Purification and Characterization of Involucrin and Involucrin-like 
Protein 
Dog esophagus was kept in 1 M NaCl containing protease inhibitors 
and 1 mM EDTA for 3 days to remove  mucous membrane. Dog  liver 
slices were washed free of blood. Oesophagus and liver samples were 
homogenized in isotonic phosphate buffer containing protease inhib- 
itors and 20 mM EDTA. After ultracentrifugation the cytosol fraction 
was made 10%  in glycerol and 62.5 mM in Tris-HC1, pH 6.8, heated 
for 10 min at 100 “C, and centrifuged (14). The proteins of the 
supernatant were precipitated in 1 2 %  trichloroacetic acid, centri- 
The abbreviations used are:  HPLC, high performance liquid chro- 
matography; PAGE, polyacrylamide gel electrophoresis; ECL, en- 
hanced chemiluminescence detection system; dansyl, 5-dimethylam- 
inonaphthalene-1-sulfonyl. 
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fuged, and redissolved at  pH 8. Cold ethanol was added in a final 
concentration of 67%, and  the precipitated  proteins were removed by 
centrifugation. The supernatant was rotary evaporated and redis- 
solved in water (15). The protein content of the fractions was deter- 
mined by Bradford's method (16), separated on SDS-PAGE (17), and 
analyzed by Western blot technique. To determine the amino acid 
composition the proteins were transferred to polyvinylidene difluoride 
membranes (Millipore), and  after staining with Ponceau S the appro- 
priate bands were cut  out, destained, and acid-hydrolyzed. 
Peptide Mapping-The proteins were eluted from the gel and 
incubated with trypsin for 1 h. After the addition of 5 pl of 50% 
trifluoroacetic acid the fragments were separated by HPLC on a C18 
column. 
Electrophoresis in Nondenaturing Conditions-Electrophoresis was 
carried out as described (14) omitting SDS from the gel and the 
running buffer. 
Incorporation of Dansyl Cadaverine into Purified Proteim-Pro- 
teins separated by electrophoresis without SDS were transferred to 
nitrocellulose membrane, the membrane was  blocked with polyvinyl- 
pyrrolidone-40 (18) and incubated with tissue transglutaminase (2.5 
pg/ml in 50 mM Tris-HC1 buffer, pH 7.5,  2 mM dithiothreitol, 10 mM 
CaC12) in the presence of dansyl cadaverine (1 mM) at 37 "C, and  the 
thoroughly washed membrane was observed under UV light. 
Immunohistochemistry-Processing of dog liver samples for im- 
munohistochemistry was carried out  as described earlier (4), and  the 
immunoreactivity was demonstrated with the peroxidase-anti-per- 
oxidase method (19,  20) followed  by slight counterstaining with 
Mayer's hemalum. 
RESULTS 
Comparison of Cornified Envelopes and Apoptotic Bodies- 
Comparing  human  and  rat cornified  envelopes with  rat  and 
dog  apoptotic bodies  purified  by appropriate  methods (2, 6), 
similarities in their morphological, physical, and chemical 
properties  can be readily  observed. They  are polygonal,  rigid 
structures with 10-30-pm diameters  and  characteristic  resist- 
ance  to  detergents  and  chaotropic  agents. Acid or  base  hy- 
drolysis and proteolytic digestion destroy them. The t(7- 
glutamy1)lysine cross-link content of cornified envelopes is 
10-20 nmol/pmol amino acid with 15-20%  of lysines  engaged 
in  this bond. In  apoptotic bodies these  numbers  are  somewhat 
lower, but  still  unusually high: 2-5 nmol of cross-link/pmol 
of amino acid  involving 6-10%  of lysine content (2, 6). After 
determining  the  amino acid  composition of these  structures, 
several common features could also be observed; the main 
components  are Gly, Pro,  Ser,  and Glx, and  the  amount of 
Asx and  Thr  is  the lowest in  both  (Table I). These results 
have  suggested to  us  that  in  spite of their very different origin 
the cornified  envelopes and  the  apoptotic bodies may be built 
up  from  similar  components. 
Isolation and Characterization of an  Involucrin-like Protein 
from Liver-To purify involucrin from dog liver  homogenate 
proteins were separated using a combination of methods 
developed for  the  isolation of human  and dog keratinocyte 
involucrin (14, 15, 21). Samples have been enriched mainly 
in two proteins (Fig. lA),  and  one of them showed specific 
immunoreactivity using either anti-human-133 (Fig. 1B) or 
anti-dog (Fig. IC) involucrin  antibodies. Starting from 1 g of 
dog liver approximately  10 pg of involucrin-like protein could 
be purified. When  it was compared  to dog  involucrin  isolated 
from  squamous  epithelia of the esophagus, the relative molec- 
ular mass and immunoreactivity of the two proteins were 
identical (Fig. 1D).  The molecular mass is in close correlation 
with that  reported  for dog keratinocyte involucrin (11, 21). 
The  keratinocyte involucrin has  an acidic isoelectric point 
and,  when  separated  on polyacrylamide gel in  the  absence of 
SDS,  migrates  as a distinct  band  (14).  Examining  the liver 
protein  under  these  circumstances,  it showed this  character- 
istic acidic property (Fig. lE, lane 5 )  similarly to esophagus 
involucrin  (Fig. lE ,  lane 6). To prove that  the purified pro- 
teins are substrates of tissue transglutaminase, the bands 
were transferred  to nitrocellulose membrane  and  incubated 
with guinea pig liver  enzyme in  the presence of dansyl cadav- 
erine, an established amine substrate of transglutaminases 
(22); intensive fluorescence appeared  in  the position of both 
esophagus  and liver protein (Fig. 1F). When  the  incubation 
was carried  out  in  solution  and  the  products were separated 
on SDS-PAGE, the involucrin bands disappeared and an 
intensive  fluorescent  staining  appeared  on  the  top of the gel 
even after a  very short  incubation  time  (data  not  shown). 
Comparing  the  amino acid  composition of the two protein, 
almost  the  same relative amounts of Thr, Arg, Val, and Leu 
were found  in  them,  but differences in  their Glx, Gly, and Ala 
content could be observed (Table  I). However these  data  are 
not  in complete agreement with the  amino acid  composition 
reported in the  literature (Ref. 11; Table I). The difference 
may arise from the low extractability of dicarboxylic amino 
acids  after acid  hydrolysis in glass containers  (23),  from  the 
difference  in the  purification  and  analytical  methods applied 
or from the  heterogeneity  in dog involucrins. 
TABLE I 
Amino  acid analvsis 
Amino acid Cornified envelopes Apoptotic bodies Involucrin-(like protein) 
(%) Human Rat Rat Dog Liver Esophagus Dog" 
Asx 0.7 0.3  1.4 1.6 9.8 10.5 
Glx 7.1 4.8  9.3 9.6 15.7 16.6 48.6 
Ser 9.7 8.9 8.3 8.2 4.5 4.8 
GlY 23.2 11.4 23.7 23.4 9.3 10.3 4.0 
His 2.6 4.4 3.5 3.9 4.4 4.6  2.4 
Thr 1.6 1.2  2.1 2.3 1.1 1.1 
Ala 4.1 7.4  5.9 13.7 9.4 10.5 
Arg 3.1 8.6 4.3 6.9 4.8 4.9 6.8 
Pro 14.6 8.5  10.6 10.2 2.7  2.9 
TY r 7.1 4.7 12.5 3.0  6.6 6.1 
Val 2.5 7.5  3.7 3.0 1.7 1.7 
CYS 1.4 1.6  0.1 0.8 ND ND 
Met ND ND   ND  ND ND 
Ile 4.6 8.0 2.0 2.0 2.5 2.9 
Leu 4.1 14.3 5.6 4.4  12.7 12.8 9.1 
Phe 2.3 2.3 3.3 2.3 5.0 4.4 
LYS 11.3 6.1  3.7 3.3 7.4 7.8 6.6 
a See Ref. 11. 
* ND, not determined. 
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FIG. 1. Purification and  characterization of involucrin-like 
protein from dog liver. Proteins  separated  either  on  SDS-PAGE 
(A-D)  or in nondenaturing electrophoresis ( E  and F) on a 7.5% 
acrylamide gel, were stained with Coomassie Blue ( A  and E )  or 
transferred to nitrocellulose membrane (B-D, F). Transblots were 
analyzed with anti-human-133 involucrin antibody ( B )  and with anti- 
dog involucrin antibody (C and D). In A-D each lane was loaded with 
100 pg  of proteins: lane 1 ,  cytosol fraction of  dog liver; lane 2, heat- 
soluble protein fraction; lane 3, proteins redissolved at  pH 8 after 
trichloroacetic acid precipitation; lane 4, proteins soluble in 67% 
ethanol; lane 5, purified involucrin of dog liver, as in lane 4; lane 6, 
involucrin isolated from dog esophagus. The position of the molecular 
weight standards is indicated on the left. E and F ,  lanes were loaded 
with 1 mg  of the purified liver (lane 5) and esophagus (lane 6 )  protein; 
no molecular weight markers are included as they do not produce 
discrete band. F, after blocking the membrane was incubated with 
tissue transglutaminase in the presence of dansyl cadaverine. After 3 
days of incubation at 37 "C, the membrane was washed and the 
reaction was detected under UV light. 
The  pattern of tryptic  fragments  obtained by HPLC sepa- 
ration was almost identical comparing the liver and esophagus 
protein (Fig. 2). The N-terminal residue of both proteins are 
blocked. Primary  amino acid sequence (deduced from cDNA) 
of dog involucrin shows that only one internal methionine 
residue (the 47th amino acid from the N terminus) is present 
(24). When the involucrin-like protein of the liver was treated 
with cyanogen bromide and  the digest was analyzed by SDS- 
PAGE, two fragments (66 and 17  kDa)  appeared  on the gel 
(data not shown). 
Histological  Localization of Znvolucrin-like Protein  in Liver 
Cells-By anti-dog involucrin antibody  immunostaining was 
observed in 20-30%  of the hepatocytes showing a  haphazard 
fashion (Fig. 3A, arrows). The immunoreactive hepatocytes 
tended to occur in clusters, without sign of zonality with 
respect to  the hepatic lobules. The  staining was diffuse cyto- 
plasmic similar to  that of involucrin observed in the spinous 
layer of keratinocytes. Epithelial cells of bile ducts were also 
decorated (data not shown). The strongest immunoreactivity 
was observed in intrasinusoidal cells (Fig. 3A, arrowheads). 
These cells represent  most likely polymorphonuclear granu- 
locytes but  the intense cytoplasmic reaction precluded their 
identification with certainty as such. When  anti-human-133 
involucrin antibody was used as  the primary  antibody  similar 
cytoplasmic reaction was observed in the hepatocytes (Fig. 
3B, arrows) and duct  epithelial cells. Intensive staining oc- 
curred  in the apoptotic hepatocytes (Fig.  3C, arrows). Immu- 
noreactivity was completely absent from sections treated with 
non-immune  rabbit serum instead of the involucrin antibodies 
(Fig. 30).  
Detection of the Znvolucrin-like Protein  in Apoptotic Bod- 
ies-To solubilize the cross-linked structures  CNBr digests of 
the cornified envelopes and  the apoptotic bodies were pre- 
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FIG. 2. Tryptic digestion pattern of involucrins. Involucrin 
containing bands of SDS gels  were electro-eluted, and  the proteins 
were incubated with trypsin for 200 min. The fragments were sepa- 
rated by HPLC on a C18 column (0.4 X 25 cm, 5 pm, BST Budapest). 
The eluents were as follows: A, 0.1% trifluoroacetic acid/water; B, 
0.08% trifluoroacetic acid/acetonitrile. The separation was carried 
out after  a 3-min wash in 100% A, with a linear gradient of  0-8075 B 
in 32 min. The flow rate was 1 ml/min, with detection at 214 nm. A, 
fragments from liver; B, fragments from esophagus protein. The arrow 
indicates an  extra peak of esophagus protein as  a major difference. 
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FIG. 3. Immunohistochemical detection of involucrin-like 
protein in dog liver cells. Staining  pattern of formaldehyde fixed 
dog liver with anti-dog involucrin antibody ( A ) ,  with anti-human- 
133 involucrin antibody ( B  and C), and using non-immune serum as 
the first antibody (D). Arrows indicate stained hepatocytes ( A  and 
B )  and engulfed apoptotic bodies (C). Arrowheads on A indicate 
stained polymorphonuclear granulocytes. The bars represent 40  pm. 
pared. They were tested by dot blot analysis with anti-invol- 
ucrin antibodies. Positive reactions could be detected either 
with anti-human-133 (Fig. 4A) or with anti-dog involucrin 
antibody (Fig. 4B) in case of both cornified envelopes and 







FIG. 4. Detection of involucrin-like protein in apoptotic 
bodies. Cornified  envelopes and  apoptotic bodies of different species 
were treated with CNBr  and  tested  on  dot  blot  with  anti-human-I33 
involucrin antibody  (A), with anti-dog involucrin antibody ( B ) ,  with 
anti-human cornified  envelope antibody (C), and with non-immune 
rabbit  serum (D). Sample I, human cornified  envelope;  sample 2, dog 
apoptotic body; sample 3 rat cornified  envelope;  sample 4 rat  apop- 
totic body. 
apoptotic bodies of various  origin. An anti-cornified envelope 
antibody which does not recognize involucrin  in cultured cells 
(12) also  reacted with  the  apoptotic bodies (Fig. 4C). When 
the apoptotic bodies were digested with  proteinase K and  then 
tested  with  anti-dog involucrin antibody  on  Western  blot  with 
a n  ECL  detection  system, positive reaction could be observed 
on  the  top of the 4% stacking gel and diffuse staining close to 
the  front of the 10% separating gel (data  not  shown). 
DISCUSSION 
Involucrin has been  used as a marker of terminal differen- 
tiation in normal  and neoplastic human  skin  (25)  as well as 
in lung carcinomas (26). However, the correlation between 
involucrin  expression and  terminal  differentiation is not gen- 
eral.  Since involucrin is an envelope precursor,  one may expect 
that  its cellular appearance coincides with  that of the enve- 
lope-producing keratinocyte transglutaminase. It has been 
demonstrated that the induction of the two proteins may 
differ in cultured squamous carcinoma cells and may be 
modulated  differently by physiological and  toxic  agents (27). 
The diagnostic utility of involucrin in the typing of lung 
tumors also has been questioned (28), because tumors of 
nonepithelial origin  showed  involucrin  expression. 
Our results show that from dog liver an  involucrin-like 
protein, which is either  identical  to  or  an isoform of keratin- 
ocyte involucrin, can be purified and both the liver and 
esophagus  protein  can serve as  acceptor  substrate for tissue 
transglutaminase in uitro. When  Chinese  hamster ovary  cells, 
which contain exclusively tissue  transglutaminase, were sta- 
bly transfected with a constitutive expression plasmid of 
human involucrin, the synthesized protein became cross- 
linked following influx of Ca2+ into  these cells  (29).  Based on 
these data we assume that involucrin may posses a wider 
function in living organisms  than  serving  as  one of the build- 
ing blocks of the cornified envelope. Immunohistochemical 
studies  on  the liver sections clearly demonstrate  the  presence 
of involucrin-like immunoreactivity in hepatocytes. The is- 
land-like  appearance  and  the  absence of the  protein  in  many 
hepatocytes suggest that  its  synthesis  might be linked  to a 
strongly  supported by the presence of involucrin  antigenicity 
in dying  cells and in the isolated,  cyanogen bromide-digested 
apoptotic bodies. The fact that the anti-human cornified 
envelope antibody also  reacted with  the  apoptotic bodies on 
dot blots, although  it does not recognized human involucrin 
(12), suggest that  there  might be even further precursor  pro- 
teins mutually used for producing cornified and apoptotic 
envelopes. Furthermore, we could isolate the involucrin-like 
protein from other  parenchymal  tissues  with significant  apop- 
tosis  rate  such  as kidney and spleen (data  not shown). 
Terminal  differentiation of stratifying  epithelia  and apop- 
tosis of parenchymal cells are different forms of naturally 
occurring cell death.  The two  processes  have distinct features 
(7, 8). The  duration of terminal differentiation is 1 month, 
whereas  apoptosis  takes place within 4-18 h;  the elimination 
of dead cells is desquamation in cornification and usually 
phagocytosis in apoptosis. However the common features 
seem to be more characteristic (7, 8). 1) Intrinsic control 
mechanisms utilize  bcl-2 protein  as a physiological blocker in 
both cases (7,30).  2)  Elimination of cells occurs without tissue 
destruction,  inflammation,  or  scar  formation.  3)  Both proc- 
esses  are triggered by calcium  ions and modulated by  gluco- 
corticoids as well as retinoids. 4) Disintegration of DNA into 
nucleosome-sized fragments by an endogenous  endonuclease 
occurs (31). 5) Encapsulation of cells by a highly cross-linked 
protein envelope  catalyzed by a transglutaminase.  6) Finally, 
our  present  results suggest that  these  transglutaminases may 
use the  same  or  similar  substrate  proteins  to form the cross- 
linked envelopes. 
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